Therapeutic Drug Monitoring to Spike to $2.69 Billion by 2019
Commercial & Investment Banking, Picture Gallery Monday, March 18th, 2013
NEW YORK, NY — (Marketwire) — 03/18/13 — TriMarkPublications.com cites in its newly published "" report that (TDM) will spike to $2.69 billion by 2019. For more information, visit: .can be categorized into seven main modalities: antiepileptics, antiarrhythmics, antibiotics, antineoplastics, bronchodilators, immunosuppressives and HIV/AIDS drugs. The global market is dominated by eight major suppliers that account for a combined 88.3% of the global market. The U.S. market is expec
